PNA and VVA B4 recognize the tumor-associated T antigen and its immediate precursor Tn, respectively. We found have been identified in the cancer-associated mucin (MUC-1 that both lectins are highly reactive in vitro, with human ovarian gene product) antigen, which is a unique high molecular carcinoma cell lines, but only VVA B4 bound significantly to weight surface glycoprotein, overexpressed in more than breast and oral cancer cells. This binding is inhibited by specific 90% of the human ovarian cancers and in the large majority monosaccharides. The lectin binding receptors were purified, of breast carcinomas types [5]. revealing a glycoprotein of 32 kDa for PNA, and twoWe have previously shown that monoclonal (rodent)and glycoproteins of 35 and 38 kDa for VVA B4. In vivo localization polyclonal (human) anti-T and -Tn antibodies are reactive of PNA was almost exclusive (except for the kidneys) to the with the human ovarian IGROV-1, OVCAR-3 and SKOV-3 ovarian tumor xenografts. VVA B4 showed wider tissue carcinoma cells and accumulate in vivo, in ovarian carcinobiodistribution being preferentially accumulated in the tumors and ovaries, mas xenografted in nude mice [6]. In vitro, the monoclonal anti-T/Tn antibodies are cytotoxic to the ovarian cancer cells